Author

Julian Panés 1

1 Hospital Clínic Barcelona Dept. of Gastroenterology - Dept. of Gastroenterology, Hospital Clínic Bar,Barcelona,Spain

A COMPREHENSIVE MOLECULAR CLASSIFICATION OF CROHN'S DISEASE USING GENE EXPRESSION DATA

Kevin Perez, Lionel Le Bourhis, Marjolaine Ngollo, Julian Panés, Azucena Salas, Philippe Seksik, Dirk Haller, Mark J. Daly, Matthieu Allez

A NOVEL SIMPLE SCORE FOR THE DIAGNOSIS OF CROHN’S DISEASE

Sieglinde Reinisch, Karin Schweiger, Eleonore Pablik, Benjamin Collet-Fenetrier, Laurent Peyrin-Biroulet, Julian Panés, Walter Reinisch

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A SELECTIVE, ORAL SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, ETRASIMOD (APD334), IN MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE OASIS STUDY

William Sandborn, Laurent Peyrin-Biroulet, Luba Trokan, Jinkun Zhang, Tanja Kühbacher, Michael Chiorean, Scott D. Lee, Severine Vermeire, Bruce Yacyshyn, Snehal U. Naik, Preston Klassen, Julian Panés

AN UPDATE ON THE ANALYSIS OF NON-MELANOMA SKIN CANCER IN THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAMME AS OF MAY 2019

Bruce E. Sands, Walter Reinisch, Julian Panés, Paulo Gustavo Kotze, Donna T Judd, Rajiv Mundayat, Nervin Lawendy

An update on the analysis of non-melanoma skin cancer in the tofacitinib ulcerative colitis programme

Bruce E. Sands, Millie D. Long, Leonard Baidoo, Walter Reinisch, Julian Panés, Arif Soonasra, Ronald D. Pedersen, Nervin Lawendy, Gary Chan

ANALYSIS OF NON-MELANOMA SKIN CANCER IN THE ULCERATIVE COLITIS PROGRAMME FOR TOFACITINIB

Julian Panés

ANALYSIS OF NON-MELANOMA SKIN CANCER IN THE ULCERATIVE COLITIS PROGRAMME FOR TOFACITINIB

Bruce E. Sands, Millie D. Long, Leonard Baidoo, Walter Reinisch, Julian Panés, Chudy I. Nduaka, Arif Soonasra, Ronald D. Pedersen, Nervin Lawendy, Gary Chan, Gary S. Friedman, Chinyu Su

ASSOCIATION BETWEEN PROPOSED DEFINITIONS OF CLINICAL REMISSION/RESPONSE AND WELL-BEING IN PATIENTS WITH CROHN'S DISEASE

William Sandborn, James D Lewis, Julian Panés, Edward V. Loftus, Jr, Geert R. D'Haens, ZHUQING YU, Bidan Huang, Ana P. Lacerda, Aileen L Pangan, Brian G. Feagan

Azathioprine: Declining usage justified?

Julian Panés

Cell therapy

Julian Panés

Item 1 - 10 / 100
1
2 3 4 5 6 7
...
9 10